IntelliCyt Corporation develops innovative, high-throughput, high-content cell and bead-based screening solutions for use in phenotypic drug discovery, antibody discovery and in vitro toxicity testing.
IntelliCyt Corporation develops innovative, high-throughput, high-content cell and bead-based screening solutions for use in phenotypic drug discovery, antibody discovery and in vitro toxicity testing.
Swift Biosciences is a fast-moving company focused on developing enabling technologies and products for genomics and personalized medicine. Its technologies provide customers with powerful new methods to examine disease-related genes.